Journals / Nöropsikiyatri Arşivi / 2011 / Cilt: 48 - Sayı: 3

An adolescent with obsessive-compulsive disorder with poor ınsight who was cured by using aripiprazole and literature review

Aripiprazol ile iyileşen “iç görüşü kısıtlı” obsesif kompulsif bozukluk tanılı bir ergen ve literatürün gözden geçirilmesi

Pages
215–220
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on this case,we aim to discuss the diagnosis, differential diagnosis and treatment of OCD with poor insight and to share the data on the prognosis in our patient. (Archives of Neuropsychiatry 2011; 48: 215-20)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obsessive compulsive disorder (OCD) with poor insight is one of the most severe disorders of OCD spectrum and has a poor prognosis.
📊
Key Findings & Data:In this article, we aim to discuss a 15-year-old male adolescent who was suspected to have OCD with poor insight and had overvalued ideas and had responded poorly to SSRI and CBT treatments.
💡
Conclusion & Impact:Based on this case,we aim to discuss the diagnosis, differential diagnosis and treatment of OCD with poor insight and to share the data on the prognosis in our patient. (Archives of Neuropsychiatry 2011; 48: 215-20)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Obsessive compulsive disorder (OCD) with poor insight is one of the most severe disorders of OCD spectrum and has a poor prognosis. Compared with other OC spectrum disorders, it has different prognosis and treatment response. There are several studies suggesting augmentation of selective serotonin reuptake inhibitor (SSRI) treatment and cognitive behavioral therapy (CBT) with atypical antipsychotics due to poor response to standard OCD treatment in this subgroup. In this article, we aim to discuss a 15-year-old male adolescent who was suspected to have OCD with poor insight and had overvalued ideas and had responded poorly to SSRI and CBT treatments. After we added aripiprazole to SSRI, his symptoms totally disappeared and the former functioning was achieved. Based on this case,we aim to discuss the diagnosis, differential diagnosis and treatment of OCD with poor insight and to share the data on the prognosis in our patient. (Archives of Neuropsychiatry 2011; 48: 215-20)

Özet

“İç görüşü kısıtlı” Obsesif Kompulsif Bozukluk (OKB) tanımı, OKB spektrumunda en ağır gidiş ve sonlanım ile karakterize, daha karmaşık bir klinik seyir gösteren, standart farmakolojik ve bilişsel davranışçı tedavilere kötü yanıt veren ve daha kötü prognoz ile ilişkilendirilen bir grup hastayı kapsamaktadır. Standart OKB tedavisine yanıtın bu alt grupta kısıtlı olması nedeniyle SSRI tedavisinin bir atipik antipsikotik eklenmesini öneren yayınlar bulunmaktadır. Bu makalede belirtileri başladıktan 3 yıl sonra, belirtilerinin ağırlaşması nedeniyle polikliniğimize başvuran “iç görüşü kısıtlı OKB” tanısı düşünülen, aşırı değerlenmiş düşünceleri bulunan 15 yaşında bir erkek ergen, standart BDT ve farmakolojik tedavilerden yanıt alınamaması üzerine SSRI tedavisine aripiprazol eklenmesi sonrası belirtilerinin kaybolması ve eski işlevselliğine geri dönmesi nedeniyle ele alınmıştır. Olgu temelinde tanı, ayırıcı tanı ve tedavi ile ilgili bilgiler değerlendirilmiş, olgunun klinik seyrine dair veriler paylaşılmıştır. (Nöropsikiyatri Arşivi 2011; 48: 215-20)

🔖

Cite This Article

PEKCANLAR, A. A., CENGİZHAN, S., KIVIRCIK, B. B. A. (2011). An adolescent with obsessive-compulsive disorder with poor ınsight who was cured by using aripiprazole and literature review. Nöropsikiyatri Arşivi, Cilt: 48 - Sayı: 3, 215–220. https://ajindex.com/articles/294421

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bebbington PE. Epidemiology of obsessive-compulsive disorder. Br J Psychiatry Suppl 1998; 2-6
  2. Kalra S K. Swedo SE. Children with obsessive-compulsive disorder: are they just “little adults”? J Clin Invest 2009; 119:737-46
  3. Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006; 29:353-70
  4. American Psychiatric Association and American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association. Washington: DC, USA; 2000; S. 943
  5. Lewin BA, Bergman RL, Peris TL et al. Corraletes of Insight Among Youth with Obsessive- Compulsive Disorder. J Child Psycology and Psychiatry 2010; 51:603-11
  6. Storch EA, Merlo LJ. Obssesive-compulsive disoreder: strategies for using CBT and pharmacotherapy. J Fam Pract 2006; 55:329-33
  7. Denys D, De Geus F, Van Megen H et al. A double-blind, randomized,placebo-controlled trial of quetiapine addition in patients with obssesive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65:1040-8
  8. Erzegovesi S, Guglielmo E, Siliprandi F et al. Low-dose agumentation of fluvoxamine treatment in obssesive-compulsive disorder: A double-blind, placebo-controlled study. Eur Neuropsychopharmacol 2005; 15:69-74
  9. Hollander E, Baldini rossi N, Sood E et al. Risperidone agumentation in treatment-resistant obssesive-compulsive disorder: A double-blind, placebo-controlled study. Int J Neuropsychopharmacol 2003; 6:397-401
  10. Shapira NA, Ward HE, Mandoki M et al. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obssesive compulsive disorder. Biol Psychiatry 2004; 55:553-5
  11. Fineberg NA, Sivakumran T, Roberts A et al. Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. Int Clin Psychopharmacol 2005; 20:223-6
  12. Thomsen PH. Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: a case-series. Ann Clin Psychiatry 2004; 16:201-7
  13. Kuroki T, Nagao N, Nakahara T. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res 2008; 172:199-212. 14. da Rocha FF, Correa H. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1550-1
  14. Fornaro M, Gabriel